↓ Skip to main content

PLOS

What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines

Overview of attention for article published in PLOS ONE, September 2008
Altmetric Badge

Mentioned by

policy
1 policy source
wikipedia
1 Wikipedia page

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
116 Mendeley
Title
What Should Vaccine Developers Ask? Simulation of the Effectiveness of Malaria Vaccines
Published in
PLOS ONE, September 2008
DOI 10.1371/journal.pone.0003193
Pubmed ID
Authors

Melissa A. Penny, Nicolas Maire, Alain Studer, Allan Schapira, Thomas A. Smith

Abstract

A number of different malaria vaccine candidates are currently in pre-clinical or clinical development. Even though they vary greatly in their characteristics, it is unlikely that any of them will provide long-lasting sterilizing immunity against the malaria parasite. There is great uncertainty about what the minimal vaccine profile should be before registration is worthwhile; how to allocate resources between different candidates with different profiles; which candidates to consider combining; and what deployment strategies to consider.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 7 6%
Germany 2 2%
Netherlands 1 <1%
Canada 1 <1%
Australia 1 <1%
Unknown 104 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 20%
Student > Ph. D. Student 22 19%
Student > Master 18 16%
Student > Postgraduate 8 7%
Student > Doctoral Student 8 7%
Other 22 19%
Unknown 15 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 34 29%
Medicine and Dentistry 30 26%
Computer Science 7 6%
Nursing and Health Professions 5 4%
Mathematics 4 3%
Other 16 14%
Unknown 20 17%